Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?
-
Emmanuel J. Favaloro
Abstract
The prothrombin time (PT) assay is the most often requested coagulation test and used primarily for monitoring Vitamin K antagonist therapy, where results may be expressed as an International Normalised Ratio (INR). The INR is the patient's PT ‘mathematically adjusted’ or ‘standardised’ to take into account the specific test system used (i.e., comprising the test reagent/instrument combination). This standardisation or ‘adjustment’ is achieved by applying two ‘correction factors’, respectively defined by the ‘International Sensitivity Index’ (ISI) and the ‘mean normal prothrombin time’ (MNPT), according to the formula: INR=[patient PT/MNPT]ISI. While some manufacturers provide assigned ISI values for specific PT reagents and instrumentation, the vast number of possible reagent/instrument combinations usually precludes this in most situations. Even when an ISI is provided by the manufacturer, laboratories need to check or validate the assigned value. When a manufacturer does not provide an ISI, the laboratory needs to define its own (local ISI) value. The MNPT usually has to be locally defined, based on the population being tested. Current recommendations for defining ISI values include the classical, but prohibitively complex, World Health Organization (WHO) recommended procedure, and more recently the use of commercial reference-plasma calibration sets. The MNPT can also be defined using the WHO recommended procedure or with calibration sets. However, there is limited information to validate the performance of these in laboratory practice, and there are several unrecognised problems that limit the validity and utility of the ISI and MNPT values that are determined. Thus, it is perhaps time to start thinking outside the box, and to utilise additional methods for determining and/or validating ISI and MNPT values. This may include the use of regression analysis to assess ongoing peer-related performance in external quality assurance programmes, and to compare the behaviour of proposed replacement reagents with that of existing reagents. Such strategies have proven of considerable benefit to local laboratory practice, and should therefore enable other laboratories to optimise their practice in order to provide INRs that better reflect a patient's anticoagulant status, and thus assist in their clinical therapeutic management.
Clin Chem Lab Med 2010;48:1079–90.
©2010 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorials
- Errors in transfusion medicine are not only misidentifications of the recipient, but also pre-analytical and analytical errors
- Biochemical and imaging biomarkers: the search for the Holy Grail
- Reviews
- Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations
- Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins
- Minireview
- Errors in transfusion: causes and measures to avoid them
- Opinion Paper
- Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?
- Genetics and Molecular Diagnostics
- Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs
- Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay
- A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples
- General Clinical Chemistry and Laboratory Medicine
- Urine particle evaluation: a comparison between the UF-1000i and quantitative microscopy
- Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease
- Non-invasive fetal RHD genotyping in the first trimester of pregnancy
- Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia
- Comparison of cetylpyridinium chloride and cetyltrimethylammonium bromide extractive procedures for quantification and characterization of human urinary glycosaminoglycans
- Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis
- Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity
- A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry
- Reference Values and Biological Variations
- Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation
- Cancer Diagnostics
- Circulating procalcitonin in aseptic carcinoma patients: a specificity study with 18F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark
- Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma
- Thyroglobulin measurement in fine-needle aspirates of lymph nodes in patients with differentiated thyroid cancer: a simple definition of the threshold value, with emphasis on potential pitfalls of the method
- Infectious Diseses
- Evaluation of the BacT/ALERT® 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services
- Letters to the Editor
- Should the external quality assessment sample of antinuclear antibodies be of a typical monospecific pattern?
- Identification of reduced serum thrombopoietin concentrations in patients with chronic hepatitis C undergoing an interferon therapy
- Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy
- Target cell formation leading to pseudoleukocytosis in patients with malignant disorders
- Controversies on quotient reporting to standardize laboratory results
- Abstracts
- Fifth Santorini Conference Biologie Prospective 2010
Articles in the same Issue
- Editorials
- Errors in transfusion medicine are not only misidentifications of the recipient, but also pre-analytical and analytical errors
- Biochemical and imaging biomarkers: the search for the Holy Grail
- Reviews
- Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations
- Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins
- Minireview
- Errors in transfusion: causes and measures to avoid them
- Opinion Paper
- Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box?
- Genetics and Molecular Diagnostics
- Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs
- Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay
- A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples
- General Clinical Chemistry and Laboratory Medicine
- Urine particle evaluation: a comparison between the UF-1000i and quantitative microscopy
- Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease
- Non-invasive fetal RHD genotyping in the first trimester of pregnancy
- Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia
- Comparison of cetylpyridinium chloride and cetyltrimethylammonium bromide extractive procedures for quantification and characterization of human urinary glycosaminoglycans
- Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis
- Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity
- A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry
- Reference Values and Biological Variations
- Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation
- Cancer Diagnostics
- Circulating procalcitonin in aseptic carcinoma patients: a specificity study with 18F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark
- Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma
- Thyroglobulin measurement in fine-needle aspirates of lymph nodes in patients with differentiated thyroid cancer: a simple definition of the threshold value, with emphasis on potential pitfalls of the method
- Infectious Diseses
- Evaluation of the BacT/ALERT® 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services
- Letters to the Editor
- Should the external quality assessment sample of antinuclear antibodies be of a typical monospecific pattern?
- Identification of reduced serum thrombopoietin concentrations in patients with chronic hepatitis C undergoing an interferon therapy
- Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy
- Target cell formation leading to pseudoleukocytosis in patients with malignant disorders
- Controversies on quotient reporting to standardize laboratory results
- Abstracts
- Fifth Santorini Conference Biologie Prospective 2010
